Publication: Mutational profile of primary breast diffuse large B-cell lymphoma
dc.contributor.author | Franco, Fernando | |
dc.contributor.author | Gonzalez-Rincon, Julia | |
dc.contributor.author | Lavernia, Javier | |
dc.contributor.author | Garcia, Juan F. | |
dc.contributor.author | Martin, Paloma | |
dc.contributor.author | Bellas, Carmen | |
dc.contributor.author | Piris, Miguel A. | |
dc.contributor.author | Pedrosa, Lucia | |
dc.contributor.author | Miramon, Jose | |
dc.contributor.author | Gomez-Codina, Jose | |
dc.contributor.author | Rodriguez-Abreu, Delvys | |
dc.contributor.author | Machado, Isidro | |
dc.contributor.author | Illueca, Carmen | |
dc.contributor.author | Alfaro, Jesus | |
dc.contributor.author | Provencio, Mariano | |
dc.contributor.author | Sanchez-Beato, Margarita | |
dc.contributor.authoraffiliation | [Franco, Fernando] Hosp Univ Puerta Hierro, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Provencio, Mariano] Hosp Univ Puerta Hierro, Med Oncol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Franco, Fernando] GOTEL Spanish Lymphoma Oncol Grp, Madrid, Spain | |
dc.contributor.authoraffiliation | [Lavernia, Javier] GOTEL Spanish Lymphoma Oncol Grp, Madrid, Spain | |
dc.contributor.authoraffiliation | [Miramon, Jose] GOTEL Spanish Lymphoma Oncol Grp, Madrid, Spain | |
dc.contributor.authoraffiliation | [Gomez-Codina, Jose] GOTEL Spanish Lymphoma Oncol Grp, Madrid, Spain | |
dc.contributor.authoraffiliation | [Rodriguez-Abreu, Delvys] GOTEL Spanish Lymphoma Oncol Grp, Madrid, Spain | |
dc.contributor.authoraffiliation | [Alfaro, Jesus] GOTEL Spanish Lymphoma Oncol Grp, Madrid, Spain | |
dc.contributor.authoraffiliation | [Provencio, Mariano] GOTEL Spanish Lymphoma Oncol Grp, Madrid, Spain | |
dc.contributor.authoraffiliation | [Sanchez-Beato, Margarita] GOTEL Spanish Lymphoma Oncol Grp, Madrid, Spain | |
dc.contributor.authoraffiliation | [Gonzalez-Rincon, Julia] Inst Invest Sanitaria Puerta Hierro Segovia de Ar, Dept Med Oncol, Grp Res Lymphomas, Madrid, Spain | |
dc.contributor.authoraffiliation | [Pedrosa, Lucia] Inst Invest Sanitaria Puerta Hierro Segovia de Ar, Dept Med Oncol, Grp Res Lymphomas, Madrid, Spain | |
dc.contributor.authoraffiliation | [Sanchez-Beato, Margarita] Inst Invest Sanitaria Puerta Hierro Segovia de Ar, Dept Med Oncol, Grp Res Lymphomas, Madrid, Spain | |
dc.contributor.authoraffiliation | [Gonzalez-Rincon, Julia] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain | |
dc.contributor.authoraffiliation | [Martin, Paloma] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain | |
dc.contributor.authoraffiliation | [Bellas, Carmen] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain | |
dc.contributor.authoraffiliation | [Piris, Miguel A.] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain | |
dc.contributor.authoraffiliation | [Lavernia, Javier] Inst Valenciano Oncol, Med Oncol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Garcia, Juan F.] MD Anderson Canc Ctr, Pathol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Martin, Paloma] Hosp Univ Puerta Hierro, Pathol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Bellas, Carmen] Hosp Univ Puerta Hierro, Pathol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Piris, Miguel A.] Hosp Univ Fdn Jimenez Diaz, Pathol Dept, Madrid, Spain | |
dc.contributor.authoraffiliation | [Miramon, Jose] Hosp Serrania Ronda, Med Oncol Dept, Malaga, Spain | |
dc.contributor.authoraffiliation | [Gomez-Codina, Jose] Hosp Univ & Politecn La Fe, Med Oncol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Rodriguez-Abreu, Delvys] Hosp Univ Insular Gran Canaria, Med Oncol Dept, Las Palmas Gran Canaria, Spain | |
dc.contributor.authoraffiliation | [Machado, Isidro] Inst Valenciano Oncol, Pathol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Illueca, Carmen] Inst Valenciano Oncol, Pathol Dept, Valencia, Spain | |
dc.contributor.authoraffiliation | [Alfaro, Jesus] Inst Oncol Kutxa, Med Oncol Dept, Donostia San Sebastian, Spain | |
dc.contributor.funder | Instituto de Salud Carlos III (ISCIII) | |
dc.contributor.funder | AES-FEDER (Plan Estatal de I+D+I) | |
dc.contributor.funder | ROCHE | |
dc.contributor.funder | iPFIS predoctoral fellowship | |
dc.contributor.funder | Juan Rodes contract from ISCIII-MINECO-AES-FEDER (Plan Estatal I+D+I) | |
dc.contributor.funder | Miguel Servet contract from the ISCIII-MINECO-AES-FEDER (Plan Nacional I+D+I) | |
dc.contributor.funder | Miguel Servet II contract from ISCIII-MINECO-AES-FEDER (Plan Estatal I+D+I), Spain | |
dc.contributor.funder | Fundacion de Investigacion Biomedica Puerta de Hierro | |
dc.contributor.funder | Spanish Ministry of Economy and Competence (MINECO) | |
dc.date.accessioned | 2023-02-12T02:24:01Z | |
dc.date.available | 2023-02-12T02:24:01Z | |
dc.date.issued | 2017-11-28 | |
dc.description.abstract | Primary breast lymphoma is a rare form of extra-nodal lymphoid neoplasm. The most common histological type is the diffuse large B-cell lymphoma, which represents 60-80% of all the cases. Our study analyzes the mutational profile of the primary lymphoma of the breast through targeted massive sequencing with a panel of 38 genes in a group of 17 patients with primary breast diffuse large B-cell lymphoma. Seventy-point-five percent of the patients presented with stage IE and 29.5% with stage IIE. 44% of the cases correspond to lymphomas with germinal center phenotype and 33.3% to activated B-cell. The genes with a higher mutational frequency include PIM1 (in 50% of the analyzed samples), MYD88 (39%), CD79B, PRDM1 and CARD11 (17%), KMT2D, TNFIAP3 and CREBBP (11%). The profile of mutant genes involves mostly the NF kappa B signaling pathway. The high frequency of mutations in PIM1 compared with other lymphomas may have implications in the clinical presentation and evolution of this type of lymphoma. | |
dc.identifier.doi | 10.18632/oncotarget.21986 | |
dc.identifier.essn | 1949-2553 | |
dc.identifier.unpaywallURL | http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=21986&path%5B%5D=69695 | |
dc.identifier.uri | http://hdl.handle.net/10668/19446 | |
dc.identifier.wosID | 419562500014 | |
dc.issue.number | 61 | |
dc.journal.title | Oncotarget | |
dc.journal.titleabbreviation | Oncotarget | |
dc.language.iso | en | |
dc.organization | Área de Gestión Sanitaria Serrania de Malaga | |
dc.organization | AGS - Serranía de Málaga | |
dc.page.number | 102888-102897 | |
dc.publisher | Impact journals llc | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | primary breast lymphoma | |
dc.subject | diffuse large B-cell lymphoma | |
dc.subject | cell of origin | |
dc.subject | NFkB pathway | |
dc.subject | PIM1 | |
dc.subject | Prognostic-factors | |
dc.subject | Clinical-trial | |
dc.subject | Card11 | |
dc.subject | Malignancies | |
dc.subject | Expression | |
dc.title | Mutational profile of primary breast diffuse large B-cell lymphoma | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 8 | |
dc.wostype | Article | |
dspace.entity.type | Publication |